Experimental hyperlipemia induces insulin resistance in cats

Journal of Veterinary Medical Science

Volumn 74, Issue 2, 2012, Pages 267-269

  Nishii, Naohito ^a   Maeda, Haruka ^a   Murahata, Yusuke ^a   Matsuu, Aya ^a   Hikasa, Yoshiaki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Feline; Hyperlipemia; Insulin

Indexed keywords

FATTY ACID; TRIACYLGLYCEROL;

ANIMAL; ARTICLE; BLOOD; CAT; FEMALE; GLUCOSE BLOOD LEVEL; HYPERLIPIDEMIA; INSULIN RESISTANCE; MALE; METABOLISM; PHYSIOLOGY;

ANIMALS; BLOOD GLUCOSE; CATS; FATTY ACIDS, NONESTERIFIED; FEMALE; HYPERLIPIDEMIAS; INSULIN RESISTANCE; MALE; TRIGLYCERIDES;

FELIDAE;

EID: 84857853501     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.11-0266     Document Type: Article

References (19)

1. Belfort, R., Mandarino, L., Kashyap, S., Wirfel, K., Pratipanawatr, T., Berria, R., Defronzo, R. A. and Cusi, K. 2005. Doseresponse effect of elevated plasma free fatty acid on insulin signaling. Diabetes 54: 1640-1648.
2. Brechtel, K., Dahl, D. B., Machann, J., Bachmann, O. P., Wenzel, I., Maier, T., Claussen, C. D., Häring, H. U., Jacob, S. and Schick, F. 2001. Fast elevation of the intramyocellular lipid content in the presence of circulating free fatty acids and hyperinsulinemia: a dynamic 1H-MRS study. Magn. Reson. Med. 45: 179-183.
3. Chiu, J. D., Kolka, C. M., Richey, J. M., Harrison, L. N., Zuniga, E., Kirkman, E. L. and Bergman, R. N. 2009. Experimental hyperlipidemia dramatically reduces access of insulin to canine skeletal muscle. Obesity (Silver Spring) 17: 1486-1492.
4. DeFronzo, R. A., Tobin, J. D. and Andres, R. 1979. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237: E214-223.
5. Doberne, L., Greenfield, M. S., Rosenthal, M., Widstrom, A. and Reaven, G. 1982. Effect of variations in basal plasma glucose concentration on glucose utilization (M) and metabolic clearance (MCR) rates during insulin clamp studies in patients with non-insulin-deendent diabetes mellitus. Diabetes 31: 396-400.
6. Felber, J. P., Ferrannini, E., Golay, A., Meyer, H. U., Theibaud, D., Curchod, B., Maeder, E., Jequier, E. and DeFronzo, R. A. 1987. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36: 1341-1350.
7. Feldman, E. C. and Nelson, R. W. 2004. Canine and Feline Endocrinology and Reproduction, 3rd ed., Saunders, St. Louis.
8. Hatano, Y., Mori, N., Asada, M., Mori, A., Yamamoto, I., Muranaka, S., Kojima, M., Kigure, M., Yagishita, M., Sako, T. and Arai, T. 2010. Hypertriglyceridemia with increased plasma insulin concentrations in cats. Res. Vet. Sci. 88: 458-460.
9. Lee, K. U., Lee, H. K., Koh, C. S. and Min, H. K. 1988. Artificial induction of intravascular lipolysis by lipid-heparin infusion leads to insulin resistance in man. Diabetologia 31: 285-290.
10. Pyle, S. C., Marks, S. L. and Kass, P. H. 2004. Evaluation of complications and prognostic factors associated with administration of total parenteral nutrition in cats: 75 cases (1994- 2001). J. Am. Vet. Med. Assoc. 225: 242-250.
11. Queau, Y., Larsen, J. A., Kass, P. H., Glucksman, G. S. and Fascetti, A. J. 2011. Factors associated with adverse outcomes during parenteral nutrition administration in dogs and cats. J. Vet. Intern. Med. 25: 446-452.
12. Reaven, G. M. and Chen, Y. D. 1988. Role of abnormal free fatty acid metabolism in the development of non-insulindependent diabetes mellitus. Am. J. Med. 85: 106-112.
13. Roden, M., Krssak, M., Stingl, H., Gruber, S., Hofer, A., Fürnsinn, C., Moser, E. and Waldhäusl, W. 1999. Rapid impairment of skeletal muscle glucose transport/phosphorylationby free fatty acids in humans.
14. Roden, M., Stingl, H., Chandramouli, V., Schumann, W. C., Hofer, A., Landau, B. R., Nowotny, P., Waldhäusl, W. and Shulman, G. I. 2000. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes 49: 701-707.
15. Sako, T., Mabuchi, T., Mori, A., Motoike, T., Mizutani, H. and Hirose, H. 2007. Use of compact blood glucose monitor to measure blood glucose levels in cats and dogs. J. Anim. Clin. Med. 16: 77-81.
16. Suzuki, R., Tobe, K., Aoyama, M., Inoue, A., Sakamoto, K., Yamauchi, T., Kamon, J., Kubota, N., Terauchi, Y., Yoshimatsu, H., Matsuhisa, M., Nagasaka, S., Ogata, H., Tokuyama, K., Nagai, R. and Kadowaki, T. 2004. Both insulin signaling defects in the liver and obesity contribute to insulin resistance and cause diabetes in Irs2(-/-) mice. J. Biol. Chem. 279: 25039-25049.
17. Vigili de Kreutzenberg, S., Lisato, G., Riccio, A., Giunta, F., Bonato, R., Petolillo, M., Tiengo, A. and Del Prato, S. 1988. Metabolic control during total parenteral nutrition: use of an artificial endocrine pancreas. Metabolism 37: 510-513.
18. Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., Atcheson, B., White, M. F., Kraegen, E. W. and Shulman, G. I. 2002. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277: 50230-50236.
19. Zini, E., Osto, M., Konrad, D., Franchini, M., Sieber-Ruckstuhl, N. S., Kaufmann, K., Guscetti, F., Ackermann, M., Lutz, T. A. and Reusch, C. E. 2010. 10-day hyperlipidemic clamp in cats: effects on insulin sensitivity, inflammation, and glucose metabolism-related genes. Horm. Metab. Res. 42: 340-347.